Post-Marketing Surveillance of Humira in Korean Pediatric CD Patients Under the "New-Drug Re-examination"

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02578238

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:03.988742+00:00

Published At

2018-12-19T00:00:00+00:00

Record Updated At

2018-12-19

Results Posted At

2018-12-19

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pediatric Crohn\u0027s Disease"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-12-19"

protocolSection.identificationModule.nctId

"NCT02578238"

protocolSection.identificationModule.officialTitle

"Post-Marketing Surveillance of Humira in Korean Pediatric CD Patients Under the \"New-Drug Re-examination\""

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2018-12-19"

Study condition terms

• Pediatric Crohn's Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.